Cipla strengthens 3.9% as pharma sector sees renewed buying

Pharma heavyweight Cipla ended the day 3.90% higher at ₹1,639.30, up from ₹1,577.80 in the previous session. The stock traded between ₹1,578.40 and ₹1,647.00, showing strong accumulation throughout the session. The rise comes amid positive sector cues and expectations of continued export demand from the US and African markets. Cipla has maintained steady margins and has been focusing on high-value respiratory and chronic therapies, which could boost earnings going forward. Technical charts also indicate strong support around ₹1,560–1,570 levels, suggesting further upside potential if market sentiment remains firm. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes ***** must verify information before investing and consider their financial position & risk profile.